Invitation to presentation of Magle Chemoswed’s report for Q2 2022
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Läs mer: Investera i räntebärande lån – Historisk årlig avkastning på 9,9 % (annons)

Pressmeddelande

Invitation to presentation of Magle Chemoswed’s report for Q2 2022

MFN Publicerad: 11 Aug 2022 12:43
Magle Chemoswed

Magle Chemoswed Holding AB (publ) will publish its interim report for Q2 2022 on Wednesday 17 August 2022 at 08:30 CET.

On the same day, Wednesday 17 August at 11:00 CEST, the company will hold a web conference hosted by CEO Justin Pierce and CFO Petra Jönsson Sjölin. After their presentation, there will be a Q&A session. The conference will be held in English. You can join the conference by computer or mobile device.

The number of participants is limited and we recommend signing up early to secure a spot. Please register at the following link:
https://attendee.gotowebinar.com/register/616877025508280847

A recording of the web conference will afterwards be available on Magle Chemoswed’s homepage www.maglegroup.com and on Västra Hamnen Corporate Finance’sYouTube channel.

Contacts

Megi Medzmariashvili, Legal Counsel, phone +46 (0)76 164 33 12, [email protected]

About Us

The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Learn more on www.maglechemoswed.com and https://maglegroup.com/ and www.maglepharmacept.com

Västra Hamnen Corporate Finance is the Company's certified advisor on Nasdaq First North Growth Market and can be reached at [email protected] or +46 (0) 40 200 250.

Attachments

Invitation to presentation of Magle Chemoswed’s report for Q2 2022

Bifogade filer

Invitation to presentation of Magle Chemoswed’s report for Q2 2022https://storage.mfn.se/b005aae6-13d4-453f-80de-cce11052ef05/invitation-to-presentation-of-magle-chemosweds-report-for-q2-2022.pdf

Nyheter om Magle Chemoswed

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

Jämförelse: Vilken är Sveriges bästa fondrobot?Guide: Så börjar du spara i fonder som nybörjareTopplistor: Fonderna med bäst avkastning just nu
STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Magle Chemoswed

Senaste nytt